dallas semaglutide side effect class action At least 3,000 patients have filed lawsuits against the companies behind GLP-1 weight loss drugs, alleging severe health risks, including blindness. NewsNation's Brooke Shafer has the story on "Morning in America." Weight Loss Drugs Lawsuit |

The quadrant illustrates superior histologic efficacy in MASH resolution and fibrosis improvement compared with placebo, with favorable NNT values

Apply gentle pressure with a sterile gauze pad for 2-3 minutes, then ice the area for 10 minutes to reduce swelling

04, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate

These effects contribute to the strong weight-reducing effect of tesofensine

With the weight-threshold dosing patent covering the FDA-approved label through 2044 and compound patents providing coverage into the early 2030s, the layered structure means that any generic manufacturer faces at least three separate patent challenges simultaneously: the compound patent, the method-of-use patent for MASH treatment, and the dosing regimen patent

LiesaMPalacnMZorzanoA